Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People With HIV Who Inject Drugs
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study will implement a pilot randomized controlled trial (RCT, N=70) to refine and assess the feasibility and acceptability of an emotion regulation and communication skills intervention designed to improve engagement in HIV-care among substance using HIV+ PWID sub-optimally engaged in HIV care.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• HIV positive
• HIV virally unsuppressed (\>20 copies/mL) in past year or no past-year HIV viral load result
• Drug use behavior endorsed in past 6 months
• Able to provide informed consent
• 18 years or older
• English speaking
Locations
United States
Massachusetts
Fenway Community Health
RECRUITING
Boston
Contact Information
Primary
Abigail W Batchelder, PhD, MPH
abigail.batchelder@bmc.org
6172670900
Time Frame
Start Date: 2021-09-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 70
Treatments
Experimental: Intervention
This intervention includes 6 face-to-face therapy sessions with a trained clinician plus an incentivized directly observed therapy (iDOT) intervention facilitated via a mobile application.
Active_comparator: incentivized Directly Observed Therapy (iDOT)
Participants in the iDOT condition will be provided a mobile application to facilitate video recording of their daily medication adherence in order to receive small, escalating monetary incentives for HIV medication adherence.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), Fenway Community Health
Leads: Massachusetts General Hospital